申请人:UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
公开号:US20170087167A1
公开(公告)日:2017-03-30
Aspirin is chemically modified to generate a prodrug that releases aspirin in cellular milieu. The prodrug has a lipophilic tail that may enhance uptake efficiency in nanoparticles. Nanoparticles including the prodrugs may be effective for treating inflammatory disorders, including neurodegenerative disorders.
阿司匹林经过化学修饰,生成了一种前药,该前药能够在细胞环境中释放阿司匹林。这种前药具有亲脂性尾部,可能增强纳米颗粒中的摄取效率。包含这些前药的纳米颗粒可能对治疗炎症性疾病有效,包括神经退行性疾病。